FREMONT, Calif., April 1 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that David Gelfand, Ph.D., chief scientific officer, will deliver an executive talk at the Malaysian Ministry of Science, Technology and Innovation's (MOSTI) biotechnology conference on polymerase chain reaction (PCR). The conference will be held April 2, 2009, at the Putrajaya International Convention Centre (PICC) in Putrajaya, Malaysia.
Dr. Gelfand's executive talk, which will serve as the conference's feature event, will focus on polymerase chain reaction (PCR) and highlight the history of the revolutionary technology. During his speech, Dr. Gelfand will also outline the latest PCR-related advances, as well as potential future PCR innovations, while also discussing the broad implications the technology has in the areas of genomics and oncology. Finally, Dr. Gelfand will provide an overview of WaferGen's SmartChip Real-Time PCR System, the world's first whole genome, high throughput gene expression real-time PCR platform.
Dr. Gelfand is widely considered one of the world's foremost experts on PCR and DNA sequencing and is credited as the inventor of Thermus aquaticus (Taq) DNA Polymerase for use in PCR.
WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for genetic analysis for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip is being developed as the first whole genome, high throughput gene expression real-time polymerase chain reaction (PCR) platform. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver significant
|SOURCE WaferGen Biosystems, Inc.|
Copyright©2009 PR Newswire.
All rights reserved